
Medicare Drug Pricing Negotiations Advance
Deconstructed
Medicare Drug Pricing Negotiations and the Impact on Insulin
This chapter explores how Medicare drug pricing negotiations can benefit both Medicare beneficiaries and the general public, with a specific focus on the impact on insulin prices. It discusses the current out-of-pocket cap on insulin for Medicare beneficiaries, the need to negotiate lower prices, and the potential implications for pharmaceutical corporations.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.